Showing results (341-350 of 1,129) with videos related to
Sort By:
Pageof 113
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 20, 2014
Extended follow-up following "full-metal jacket" percutaneous coronary interventions with drug-eluting stentsSandeep Basavarajaiah, Toru Naganuma, Azeem Latib, et al.Frontiers in Cardiovascular Medicine|December 8, 2025
Safety aspects of de novo DCB-only PCI-a practical checklist and a simplified revised dissection classificationNatasha H Corballis, Ioannis Merinopoulos, Rajkumar Natarajan, et al.European Heart Journal|February 21, 2025
Individual patient data meta-analysis of paclitaxel-coated balloons vs. drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA studySimone Fezzi, Daniele Giacoppo, Gregor Fahrni, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|November 1, 2019
Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-BentallAlessandra Laricchia, Antonio Mangieri, Francesco Gallo, et al.JACC. Cardiovascular Interventions|November 15, 2020
Functional and Echocardiographic Improvement After Transcatheter Repair for Tricuspid Regurgitation: A Systematic Review and Pooled AnalysisClaudio Montalto, Alessandro Sticchi, Gabriele Crimi, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 14, 2015
Successful implantation of a second-generation aortic valve in severe aortic regurgitation secondary to a traumatic cusp lesionAntonio Mangieri, Azeem Latib, Andrea Aurelio, et al.Journal of Interventional Cardiology|October 6, 2006
An overview of the TAXUS Express, paclitaxel-eluting stent clinical trial programJohn M Lasala, Gregg W Stone, Keith D Dawkins, et al.Minerva Cardioangiologica|July 3, 2018
The future of percutaneous tricuspid valve interventionsDamiano Regazzoli, Antonio Mangieri, Ozan Demir, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 16, 2017
First in human evaluation of the vascular biocompatibility and biomechanical performance of a novel ultra high molecular weight amorphous PLLA bioresorbable scaffold in the absence of anti-proliferative drugs: Two-year imaging results in humansMiguel Moncada, Juan A Delgado, Antonio Colombo, et al.Asiaintervention|March 16, 2026
Head-to-head comparison of limus- versus paclitaxel-coated balloons in the treatment of in-stent restenosis: a meta-analysisMarios Sagris, Stergios Soulaidopoulos, Nikolaos Ktenopoulos, et al.Pageof 113